These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


347 related items for PubMed ID: 18974648

  • 21. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.
    Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT.
    Neurology; 2001 Mar 13; 56(5):643-9. PubMed ID: 11245717
    [Abstract] [Full Text] [Related]

  • 22. Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia: differentiation of dementia with Lewy bodies and Alzheimer disease when the diagnoses based on clinical and neuroimaging criteria are difficult.
    Schmidt SL, Correa PL, Tolentino JC, Manhães AC, Felix RM, Azevedo JC, Barbirato GB, Mendes MH, Boechat Y, Cabral H, Schmidt GJ, Dohmann HF, Mesquita CT.
    Clin Nucl Med; 2008 Jun 13; 33(6):398-401. PubMed ID: 18496445
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. 123I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study.
    Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamashina S, Yamasaki J, Yoshita M, Yamada M.
    J Neurol Neurosurg Psychiatry; 2018 Nov 13; 89(11):1167-1173. PubMed ID: 29853532
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S, Kanetaka H, Hirao K, Fukasawa R, Namioka N, Hatanaka H, Hirose D, Umahara T, Sakurai H, Hanyu H.
    Geriatr Gerontol Int; 2017 May 13; 17(5):819-824. PubMed ID: 27138074
    [Abstract] [Full Text] [Related]

  • 28. Potential diagnostic value of 131I-MIBG myocardial scintigraphy in discrimination between Alzheimer disease and dementia with Lewy bodies.
    Abbasi M, Ghalandari N, Farzanefar S, Aghamollaii V, Ahmadi M, Ganji M, Afarideh M, Loloee S, Naseri M, Tafakhori A.
    Clin Neurol Neurosurg; 2017 Dec 13; 163():163-166. PubMed ID: 29112909
    [Abstract] [Full Text] [Related]

  • 29. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
    Odagiri H, Baba T, Nishio Y, Iizuka O, Matsuda M, Inoue K, Kikuchi A, Hasegawa T, Aoki M, Takeda A, Taki Y, Mori E.
    PLoS One; 2016 Dec 13; 11(4):e0152746. PubMed ID: 27055151
    [Abstract] [Full Text] [Related]

  • 30. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies.
    Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, Ikeda S.
    Intern Med; 2003 Aug 13; 42(8):686-90. PubMed ID: 12924492
    [Abstract] [Full Text] [Related]

  • 31. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.
    Hanyu H, Shimizu S, Hirao K, Kanetaka H, Sakurai H, Iwamoto T, Koizumi K, Abe K.
    J Neurol Sci; 2006 Dec 01; 250(1-2):97-102. PubMed ID: 17005204
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
    Camacho V, Marquié M, Lleó A, Alvés L, Artigas C, Flotats A, Duch J, Blesa R, Gómez-Isla T, Carrió I, Estorch M.
    Q J Nucl Med Mol Imaging; 2011 Aug 01; 55(4):476-83. PubMed ID: 21150861
    [Abstract] [Full Text] [Related]

  • 35. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
    Lebasnier A, Lamotte G, Manrique A, Peyronnet D, Bouvard G, Defer G, Agostini D.
    Eur J Nucl Med Mol Imaging; 2015 Jun 01; 42(7):1043-51. PubMed ID: 25626701
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.
    Treglia G, Cason E.
    J Neuroimaging; 2012 Apr 01; 22(2):111-7. PubMed ID: 21091814
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.
    Waragai M, Yamada T, Matsuda H.
    J Neurol Sci; 2007 Sep 15; 260(1-2):57-64. PubMed ID: 17493637
    [Abstract] [Full Text] [Related]

  • 38. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, Urashima M, Inoue K.
    J Neurol Sci; 2006 Jan 15; 240(1-2):15-9. PubMed ID: 16199056
    [Abstract] [Full Text] [Related]

  • 39. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
    Treglia G, Cason E, Cortelli P, Gabellini A, Liguori R, Bagnato A, Giordano A, Fagioli G.
    J Neuroimaging; 2014 Jan 15; 24(2):149-54. PubMed ID: 23163913
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.